BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory





AI Companies (Drug Discovery)

Receptor.AI provides an AI-powered drug discovery platform for pharma, biotech and academia that covers the whole drug discovery pipeline in a flexible and scalable manner. Our AI solutions are tailored to discover novel drug candidates for the most challenging diseases with high success rates in clinical trials.

Receptor.AI’s mission is to create superior drugs, which are safe, efficient and successful in clinical trials by developing a next generation drug discovery platform based on the synergy of AI, computational chemistry and biomimetic technologies, such as organs-on-a-chip.

We dream about a world where new drugs are developed so fast, that new diseases have no chances to spread. We envision a radical minimisation of drug testing on animals and humans with improvement of their safety and efficiency by combining advanced AI with novel organ-on-a-chip technologies.

Posts Mentioning This Company

This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery

Receptor.AI, a London-based drug discovery company and NVIDIA Inception member, has successfully integrated NVIDIA BioNeMo cloud APIs with their end-to-end Computer Assisted Drug Discovery (CADD) platform. In doing so, the company has achieved significant performance improvements and cost savings by shifting virtual screening, ADMET assessment and ligand pose prediction tasks …

12 Notable AI-powered Biotech Companies Founded in 2021

Ever since the early 2000s, Artificial Intelligence (AI) has become a useful tool in various fields, from game design and speech recognition to powering driving cars and military applications. No wonder that big pharma companies are striving to keep up with technological progress and implementing AI in their internal R&D …

11 AI-powered Drug Discovery Startups Founded in 2021

The community of AI-driven biotech companies is continuously expanding, adding new players to the drug discovery race. In 2021 several dozen companies with AI-fueled platforms were founded, and they successfully continued raising funding and establishing strategic collaborations to expand their pipelines and improve computational capabilities.  In this report, we summarize …